Of relevance to AD, phosphatidylinositol binding clathrin assembly protein (PICALM) (which is a highly validated risk factor in late-onset AD (Harold et al., 2009)) is O-GlcNAcylated and its O-GlcNAcylation was increased by 2-fold in response to OGA inhibition. This evidence concerns the gene OGA and Alzheimer disease.